When biotechnology company Genzyme announced the presence of a contaminating virus at its drug-manufacturing plant in Allston, Massachusetts, in 2009, patients were told not to worry. Only a small stockpile of uncontaminated drugs existed, but the company said that it would resume production within two months.
展开▼
